INBS vs. IBRX

Last updated Jun 4, 2026

INBS (Intelligent Bio Solutions Inc.) and IBRX (ImmunityBio, Inc.) are both stocks. Both are in the Healthcare sector — INBS in Medical Devices, IBRX in Biotechnology. Over the past 5 years, INBS returned -79.60%/yr vs -16.33%/yr for IBRX. At a 0.19 correlation, their price movements are largely independent.

Performance

INBS vs. IBRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intelligent Bio Solutions Inc. (INBS) and ImmunityBio, Inc. (IBRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, INBS achieves a -74.40% return, which is significantly lower than IBRX's 262.63% return.

INBS

• 1D: -3.94%
• 1M: -2.40%
• YTD: -74.40%
• 6M: -64.78%
• 1Y: -84.75%
• 3Y*: -80.67%
• 5Y*: -79.60%
• 10Y*: —

IBRX

• 1D: -0.69%
• 1M: -3.36%
• YTD: 262.63%
• 6M: 226.36%
• 1Y: 164.94%
• 3Y*: 37.37%
• 5Y*: -16.33%
• 10Y*: -0.74%

*Multi-year figures are annualized to reflect compound growth (CAGR)

INBS vs. IBRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
INBS Intelligent Bio Solutions Inc.	-74.40%	-31.93%	-65.47%	-91.55%	-86.07%	-80.61%	-32.85%
IBRX ImmunityBio, Inc.	262.63%	-22.66%	-49.00%	-0.99%	-16.61%	-54.39%	-24.30%

Correlation

The correlation between INBS and IBRX is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.19
Correlation (All Time) Calculated using the full available price history since Dec 24, 2020	0.19

Fundamentals

Market Cap INBS : $3.89M IBRX : $7.37B
EPS INBS : -$11.83 IBRX : -$0.89
PS Ratio INBS : 0.61 IBRX : 49.04
Total Revenue (TTM) INBS : $3.91M IBRX : $140.98M
Gross Profit (TTM) INBS : $1.26M IBRX : $132.23M
EBITDA (TTM) INBS : -$11.06M IBRX : -$196.14M

Return for Risk

INBS vs. IBRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INBS

INBS Risk / Return Rank: 12
INBS Sharpe Ratio Rank: 20
INBS Sortino Ratio Rank: 13
INBS Omega Ratio Rank: 15
INBS Calmar Ratio Rank: 4
INBS Martin Ratio Rank: 9

IBRX

IBRX Risk / Return Rank: 83
IBRX Sharpe Ratio Rank: 82
IBRX Sortino Ratio Rank: 85
IBRX Omega Ratio Rank: 82
IBRX Calmar Ratio Rank: 87
IBRX Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INBS vs. IBRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intelligent Bio Solutions Inc. (INBS) and ImmunityBio, Inc. (IBRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	INBS	IBRX	Difference
Sharpe ratio: Return per unit of total volatility	-0.48	1.58	-2.06
Sortino ratio: Return per unit of downside risk	-0.89	2.72	-3.61
Omega ratio: Gain probability vs. loss probability	0.90	1.32	-0.42
Calmar ratio: Return relative to maximum drawdown	-0.94	3.91	-4.86
Martin ratio: Return relative to average drawdown	-1.36	5.78	-7.15
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

INBS vs. IBRX - Sharpe Ratio Comparison

The current INBS Sharpe Ratio is -0.48, which is lower than the IBRX Sharpe Ratio of 1.58. The chart below compares the historical Sharpe Ratios of INBS and IBRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	INBS	IBRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.48	1.58	-2.06
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.37	-0.14	-0.22
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.01	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.39	-0.12	-0.27

Drawdowns

INBS vs. IBRX - Drawdown Comparison

The maximum INBS drawdown since its inception was -99.99%, roughly equal to the maximum IBRX drawdown of -97.14%. Use the drawdown chart below to compare losses from any high point for INBS and IBRX.

Drawdown Indicators

	INBS	IBRX	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-97.14%	-2.85%
Max Drawdown (1Y) Largest decline over 1 year	-89.82%	-42.44%	-47.38%
Max Drawdown (3Y) Largest decline over 3 years	-99.46%	-79.34%	-20.12%
Max Drawdown (5Y) Largest decline over 5 years	-99.98%	-92.83%	-7.15%
Max Drawdown (10Y) Largest decline over 10 years	—	-97.03%	—
Current Drawdown Current decline from peak	-99.99%	-83.01%	-16.98%
Average Drawdown Average peak-to-trough decline	-91.54%	-83.91%	-7.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	62.19%	28.64%	+33.55%

Volatility

INBS vs. IBRX - Volatility Comparison

Intelligent Bio Solutions Inc. (INBS) has a higher volatility of 45.40% compared to ImmunityBio, Inc. (IBRX) at 22.35%. This indicates that INBS's price experiences larger fluctuations and is considered to be riskier than IBRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INBS	IBRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	45.40%	22.35%	+23.05%
Volatility (6M) Calculated over the trailing 6-month period	129.90%	89.40%	+40.50%
Volatility (1Y) Calculated over the trailing 1-year period	177.98%	105.21%	+72.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	216.50%	113.45%	+103.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	209.41%	111.40%	+98.01%

Dividends

INBS vs. IBRX - Dividend Comparison

Neither INBS nor IBRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both INBS and IBRX in my portfolio?

INBS and IBRX have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, INBS or IBRX?

INBS has higher volatility (45.40%) compared to IBRX (22.35%). In terms of maximum drawdown, INBS dropped -99.99% vs IBRX's -97.14%.

Which has better risk-adjusted returns?

IBRX currently has the higher Sharpe Ratio (1.58 vs -0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.